These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15985142)

  • 1. Surgical closure of combined symptomatic patent foramen ovale and atrial septum aneurysm for prevention of recurrent cerebral emboli.
    Klotz S; Tjan TD; Berendes E; Droste DW; Scheld HH; Schmid C
    J Card Surg; 2005; 20(4):370-4. PubMed ID: 15985142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients.
    Wahl A; Krumsdorf U; Meier B; Sievert H; Ostermayer S; Billinger K; Schwerzmann M; Becker U; Seiler C; Arnold M; Mattle HP; Windecker S
    J Am Coll Cardiol; 2005 Feb; 45(3):377-80. PubMed ID: 15680715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
    Chatterjee T; Petzsch M; Ince H; Rehders TC; Körber T; Weber F; Schneider H; Auf der Maur C; Nienaber CA
    J Interv Cardiol; 2005 Jun; 18(3):173-9. PubMed ID: 15966921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent stroke/TIA in cryptogenic stroke patients with patent foramen ovale.
    Casaubon L; McLaughlin P; Webb G; Yeo E; Merker D; Jaigobin C
    Can J Neurol Sci; 2007 Feb; 34(1):74-80. PubMed ID: 17352351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events.
    Dearani JA; Ugurlu BS; Danielson GK; Daly RC; McGregor CG; Mullany CJ; Puga FJ; Orszulak TA; Anderson BJ; Brown RD; Schaff HV
    Circulation; 1999 Nov; 100(19 Suppl):II171-5. PubMed ID: 10567299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interest of surgical closure of patent foramen ovale after stroke: a preliminary open study of 8 cases.
    Giroud M; Tatou E; Steinmetz E; Lemesle M; Cottin Y; Wolf JE; Moreau T; David M
    Neurol Res; 1998 Jun; 20(4):297-301. PubMed ID: 9618691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical closure of patent foramen ovale in patients with suspected paradoxical embolism: long-term results.
    Gasiavelis N; Grinnemo KH; Lindblom D; Dellgren G
    Scand Cardiovasc J; 2004 Dec; 38(6):375-9. PubMed ID: 15804806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical prophylaxis of recurrent stroke in patients with patent foramen ovale: a pilot study.
    Guffi M; Bogousslavsky J; Jeanrenaud X; Devuyst G; Sadeghi H
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):260-3. PubMed ID: 8751488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient cerebral ischemia in an elderly patient with patent foramen ovale and atrial septal aneurysm.
    Merante A; Gareri P; Castagna A; Marigliano NM; Candigliota M; Ferraro A; Ruotolo G
    Clin Interv Aging; 2015; 10():1445-9. PubMed ID: 26379429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is surgical closure of patent foramen ovale the gold standard for treating interatrial shunts? An echocardiographic follow-up study.
    Schneider B; Bauer R
    J Am Soc Echocardiogr; 2005 Dec; 18(12):1385-91. PubMed ID: 16376771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism.
    Cifarelli A; Musto C; Parma A; Pandolfi C; Pucci E; Fiorilli R; De Felice F; Nazzaro MS; Violini R
    Int J Cardiol; 2010 Jun; 141(3):304-10. PubMed ID: 19178959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of cerebral embolism after interventional closure of symptomatic patent foramen ovale or atrial septal defect: a diffusion-weighted MRI and neuron-specific enolase-based study.
    Oktay Tureli H; Ungan I; Tureli D; Demir B; Pirhan O; Bayrak HI; Caglar IM; Karakaya O; Inci E
    J Invasive Cardiol; 2013 Oct; 25(10):519-24. PubMed ID: 24088426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: initial and intermediate-term results of the U.S. multicenter clinical trial.
    Hong TE; Thaler D; Brorson J; Heitschmidt M; Hijazi ZM;
    Catheter Cardiovasc Interv; 2003 Dec; 60(4):524-8. PubMed ID: 14624434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous closure of patent foramen ovale.
    Bijl JM; Ruygrok PN; Hornung TS; Wilson NJ; West T
    Intern Med J; 2005 Dec; 35(12):706-10. PubMed ID: 16313545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent cerebrovascular ischaemic events in patients with interatrial septal abnormalities: a follow-up study.
    Cerrato P; Priano L; Imperiale D; Bosco G; Destefanis E; Villar AM; Ribezzo M; Trevi GP; Bergamasco B; Orzan F
    Neurol Sci; 2006 Feb; 26(6):411-8. PubMed ID: 16601933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of contrast TCD in patients with and without atrial septal aneurysm.
    Ziai WC; Oh S; Razumovsky AY; Wityk RJ
    J Neuroimaging; 2005 Jul; 15(3):250-3. PubMed ID: 15951407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exclusion of patients with arteriosclerosis reduces long-term recurrence rate of presumed arterial embolism after PFO closure.
    Dubiel M; Bruch L; Liebner M; Schmehl I; Winkelmann A; Rux S; Sonntag S; Wulff H; Grad MO; Kleber FX
    J Interv Cardiol; 2007 Aug; 20(4):275-81. PubMed ID: 17680857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent events after percutaneous closure of patent foramen ovale.
    Wallenborn J; Bertog SC; Franke J; Steinberg DH; Majunke N; Wilson N; Wunderlich N; Sievert H
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):541-6. PubMed ID: 22707325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patent foramen ovale with atrial septal aneurysm may contribute to white matter lesions in stroke patients.
    Ueno Y; Shimada Y; Tanaka R; Miyamoto N; Tanaka Y; Hattori N; Urabe T
    Cerebrovasc Dis; 2010; 30(1):15-22. PubMed ID: 20424440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.